Table 5

Changes made in round 3 related to the responses to specific questions

QuestionsChanges made
1Who has this report been written for?Dedicated subheading ‘Who is this report for” introduced
6What group of medicines does Bondronat belong to?This information, formerly in the section ‘How does Bondronat work’ repositioned in the new subsection ‘What type of medicine is Bondronat’?
9What two things were weighed up before the decision was made about whether Bondronat should be approved?Information bulleted in revised version, to aid finding and understanding
18When Bondronat was studied in the treatment of bone complications, which group of patients got a new bone problem first?Simplified through new subheading of ‘What did the studies show?’